Company: TYRA
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001193125-25-085709
Chunk: 56

Company: Tyra Biosciences, Inc.
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 56
---
. |

| (5) | MVA Investors, LLC is affiliated with Boxer Capital, LLC. Boxer Capital, LLC and MVA Investors, LLC together, at the time of the 2024 Private Placement, held 5% or more of our capital stock. Siddarth Subramony, Ph.D. is a Managing Director of Boxer Capital, LLC and at the time of the 2024 Private Placement, was a member of our Board. |

**Exchange Agreement On October 18, 2024, we entered into an exchange agreement with Boxer Capital, LLC and RA Capital Healthcare Fund, L.P. pursuant to which (i) Boxer Capital, LLC agreed to exchange 2,000,000 shares of the Company’s common stock for one or more pre-fundedwarrants to acquire an aggregate of 2,000,000 shares of common stock and (ii) RA Capital Healthcare Fund, L.P. agreed to exchange 1,000,000 shares of common stock for one or more pre-fundedwarrants to acquire an aggregate of 1,000,000 shares of common stock (each of such pre-fundedwarrants an “Exchange Warrant” and collectively the “Exchange Warrants”, and such exchanges of common stock for Exchange Warrants collectively the “Exchange”). Each Exchange Warrant has an exercise price of $0.001 per share of Common Stock, is immediately exercisable on the date of issuance and will not expire. No cash was exchanged related to the transaction. The Exchange closed on October 22, 2024. Entities affiliated with RA Capital Healthcare Fund, L.P. hold 5% or more of our capital stock, and entities affiliated with Boxer Capital, LLC held 5% or more of our capital stock at the time of the transaction. Indemnification Agreements We have entered into indemnification agreements with each of our directors and executive officers. These agreements, among other things, require us or will require us to indemnify each director (and in certain cases their related venture capital funds) and executive officer to the fullest extent permitted by Delaware law, including indemnification of expenses such as attorneys’ fees, judgments, fines and settlement amounts incurred by the director or executive officer in any action or proceeding, including any action or proceeding by or in right of us, arising out of the person’s services as a director or executive officer. Our Amended and Restated Certificate of Incorporation and Bylaws provide that we will indemnify each of our directors and officers to the fullest